Mostrar el registro sencillo del ítem
dc.contributor.author
Höcht, Christian
dc.contributor.author
Opezzo, Javier
dc.contributor.author
Bramuglia, Guillermo Federico
dc.contributor.author
Taira, Carlos Alberto
dc.date.available
2020-08-13T16:01:11Z
dc.date.issued
2006-09
dc.identifier.citation
Höcht, Christian; Opezzo, Javier; Bramuglia, Guillermo Federico; Taira, Carlos Alberto; Application of microdialysis for pharmacokinetic-pharmacodynamic modelling; Informa Healthcare; Expert Opinion On Drug Discovery; 1; 4; 9-2006; 289-301
dc.identifier.issn
1746-0441
dc.identifier.uri
http://hdl.handle.net/11336/111653
dc.description.abstract
Pharmacokinetic–pharmacodynamic (PK–PD) modelling describes the relationship between the pharmacokinetics and pharmacodynamics of a drug allowing the prediction of clinically relevant parameters. PK–PD modelling has several advantages over classical dose–response studies because it allows a better pharmacodynamic characterisation of drugs and screening of dosage– regimen. However, PK–PD studies are limited by the need for simultaneous measurement of drug tissue levels and corresponding pharmacological effects at multiple time points. The microdialysis technique is a unique research tool that allows the simultaneous determination of unbound concentrations of drugs at several tissues and its action on biochemical and clinical markers during several hours and days. Therefore, microdialysis sampling is an attractive methodology for PK–PD studies. The aim of this review is to describe the applicability of the microdialysis technique for PK–PD modelling of therapeutic agents, including the description of PK–PD modelling concepts, an overview of the microdialysis technique and the analysis of PK–PD studies using microdialysis sampling both in the preclinical and clinical setting.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Informa Healthcare
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.title
Application of microdialysis for pharmacokinetic-pharmacodynamic modelling
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-07-21T20:20:58Z
dc.journal.volume
1
dc.journal.number
4
dc.journal.pagination
289-301
dc.journal.pais
Reino Unido
dc.journal.ciudad
London
dc.description.fil
Fil: Höcht, Christian. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.description.fil
Fil: Opezzo, Javier. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
dc.description.fil
Fil: Bramuglia, Guillermo Federico. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
dc.description.fil
Fil: Taira, Carlos Alberto. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.journal.title
Expert Opinion On Drug Discovery
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1517/17460441.1.4.289
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1517/17460441.1.4.289
Archivos asociados